Buy Dabur India; target of 106: IIFL


Bangalore: IIFL is bullish on Dabur India and has recommended buy rating on the stock with a target of 106. According to IIFL, on the daily chart, Dabur India has signaled breakout from the inverted head and shoulder pattern above the levels of 101 with surge in volumes. Dabur India is an ayurvedic and natural health care company. It is engaged in manufacturing and marketing fast moving consumer goods and Ayurvedic products. It operates through three business units: consumer care division, international business division and consumer healthcare division. It has manufacturing facilities in eight states of India. As of March 31, 2010, it also had manufacturing facilities in eight countries: India, Bangladesh, Nepal, Dubai, Sarjah, Ras-Al-Khaima, Egypt and Nigeria. As of March 31, 2010, its brands included Dabur Amla, Dabur Chyawanprash, Vatika, Hajmola, FEM and Real. On April 1, 2009, it completed the merger of Fem Care Pharma. In October 2010, its subsidiary, Dabur International, acquired personal care companies of Hobi Group in Turkey. With the recommended price of 106, if the stock is bought at Friday's closing price of 103.15, the percentage of gain would be 2.68 percent.